BUY Shilpa Medicare Limited — Kunal Bothra
byKunal BothraHorizon: NA (inferred Swing (≤2wk))14 Jul 2026via NDTV Profit
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·30 Jun · 4w ago
Shilpa Biologicals Private Limited, a material subsidiary of Shilpa Medicare Limited, has been assigned a credit rating of IND A+/Stable/IND A1+ for its bank loan facilities of INR 1,250 million by In
BSE · Company Update·16 Jul · 2w ago
Shilpa Medicare Ltd has provided an intimation regarding its credit rating.
BSE · Company Update·7 Jul · 3w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

